# Prostate Cancer Diagnostic e-Trigger Manual

February, 2024

## Prostate Cancer Diagnostic e-Trigger Criteria

1.  Identify all patient records with prostate specific antigen (PSA)
    tests, defined as:

(patients ages 40-70 with PSA tests dated from January 1, 2009 to
December 31, 2009 with a value of 4.1 to 15 ng/mL ^1^*and* no PSA
greater than 4.1 ng/mL^2^ in the two years prior *and* who are alive 90
days after the diagnostic clue)

## Clinical Exclusion Criteria

2.  Previous prostate cancer (**any prior diagnosis**)

    a.  Patients with prostate cancer^3^

3.  Terminal illnesses or recent major diagnoses within **one year
    before or 90 days after** the diagnostic clue

    a.  Acute Leukemia only^4^

    b.  Hepatocellular cancer^5^

    c.  Biliary cancer^6^

    d.  Esophageal cancer^7^

    e.  Gastric cancer^8^

    f.  Head and Neck cancer \[cancer in the tongue;^9^ major salivary
        glands;^10^ gingivae;^11^ floor of the mouth;^12^ other sites
        within the oral cavity;^13^ oral;^14^ nasal;^15^
        hypopharynx;^16^ nose and sinuses;^17^ larynx;^18^ or with
        metastases to neck nodes from unknown origin^19^

    g.  Patients who had brain cancer^20^

    h.  Patients who had Kidney cancer^21^

    i.  Patients who had ovarian cancer^22^

    j.  Patients who had pancreatic cancer^23^

    k.  Patients who had lung cancer^24^

4.  Patients who have ever **in the past or within 90 days after** the
    diagnostic clue had an encounter for hospice/palliative care[^hospice]

5.  Patients who were diagnosed with prostatitis **within 30 days
    prior** to diagnostic clue^26^

6.  Patients who had a prostate biopsy performed **in the 2 years
    prior** to diagnostic clue^27^

## Expected Follow-up Criteria

1.  Patients who had a urology consult^28^ requested or completed
    > **within 90 days after** the diagnostic clue.

2.  Patients who were diagnosed with prostatitis^26^ **within 90 days
    > after** the diagnostic clue

3.  Patients who had a prostate biopsy^27^ performed **within 90 days
    > after** the diagnostic clue

4.  Patients who had a second evaluation of PSA^28^ **within 90 days**
    > after the diagnostic clue

**High risk group:** Patients with the diagnostic clue during the time
of interest, not meeting any exclusion criteria, and having none of the
outcomes.





## Footnotes

^1^

^2^

^3^ ICD-10 prostate: C61

^4^ ICD-10 leukemia: C92.00, C92.4, C92.5, C92.60, C92.01, C92.41,
C92.51, C92.02, C92.42, C92.52, C93.00, C93.01, C93.02, C94.00, C94.01,
C94.02, C94.20, C94.21, C94.22, C95.00, C95.01, C95.02; ICD-9: 205.0,
206.0, 207.0, 207.2x, 208.0

^5^ ICD-10 liver: C22.0, C22.2, C22.3, C22.4, C22.7, C22.8, C22.1,
C22.9, C78.7; ICD-9: 155.0, 155.1, 155.2, 197.7

^6^ ICD-10 biliary: C23, C24, C24.1, C24.8, C24.9; ICD-9: 156.xx

^7^ ICD-10 esophagus: C15.3, C15.4, C15.5, C15.8, C15.9; ICD-9: 150.xx

^8^ ICD-10 gastric: C16.0, C16.1, C16.2, C16.3, C16.4, C16.5, C16.6,
C16.8, C16.9; ICD-9: 151.xx

^9^ ICD-10 tongue: C02.9 (unspecified)

^10^ ICD-10 salivary gland: C08.9

^11^ ICD-10 gingivae: D00.03

^12^ ICD-10 floor of the mouth: C04

^13^ ICD-10 other sites within the oral cavity: C06.89

^14^ ICD-10 code mouth: C06.9 (unspecified)

^15^ ICD-10 code nasal cavity: C30.0

^16^ ICD-10 code hypopharynx (unspecified): C13.9

^17^ ICD-10 code nasal cavity: C30.0

^18^ ICD-10 larynx: C32.9

^19^

^20^ ICD-10 brain: C71.0, C71.1, C71.2, C71.3, C71.4, C71.5, C71.6,
C71.7, C71.8, C71.9, C79.31, C79.32, C79.49; ICD-9: 191.x, 198.3, 198.4

^21^ ICD-10 kidney: C64.9

^22^ ICD-10 ovary: C56.9, C56.1, C56.2; ICD-9: 183.0

^23^ ICD-10 pancreas: C25.0, C25.1, C25.2, C25.3, C25.4, C25.7, C25.8,
C25.9; ICD-9: 157.xx

^24^ ICD-10 lung: C34.0 to C34.3, C34.8, C34.9, C78.00, C78.01, C78.02;
ICD-9: 162.0, 162.2x, 162.3x, 162.4x, 162.5x, 162.8x, 162.9x, 163.xx,
197.0, 197.2, 197.3 (where 'x' is any value)



^26^ ICD-10 acute prostatitis: N41.0

^27^ CPT prostate biopsy: 55700

^28^ CPT urology evaluation and management: 99202-99499

